http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02066491-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f32653b31a38b163a9f2f04aab36d47c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 |
| filingDate | 2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e493e82e054102340e69d7f1e3d3ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_235d0f132dbf94a5d2842fbbda5ef2f3 |
| publicationDate | 2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02066491-A1 |
| titleOfInvention | Water soluble boswellic acids, their preparation and use for treating imflammatory conditions |
| abstract | A new composition which can be formed through a method comprising: (a) dissolving mixtures of boswellic acids in a water and alcohol solution to form a mixture; (b) adding one or more alkali salts to the mixture to form a salt solution; (c) filtering the solution to separate un-reacted alkali salt from a filtrate; and (d) recovering the soluble boswellic acid mixture from the filtrate. Additionally, the new composition can be formed by using super critical carbon dioxide. The new composition can be used to alleviate numerous inflammatory conditions, including, but not limited to, rheumatoid arthritis and osteoarthritis, colon cancer, prostate cancer and breast cancer, and a broad range of neurodegenerative conditions, such as Alzheimer"s disease and Parkinson"s disease. The composition can be administered parenterally, orally, or topically. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103193853-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10331750-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007046113-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-MI20111975-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022133020-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008058514-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103193852-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014076643-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-PD20120343-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007046113-A3 |
| priorityDate | 2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.